Cargando…
Mixed nanomicelles as potential carriers for systemic delivery of Z-GP-Dox, an FAPα-based doxorubicin prodrug: formulation and pharmacokinetic evaluation
Z-GP-Dox, the FAPα (fibroblast activation protein-α)-based doxorubicin prodrug, demonstrates excellent tumor targeting effects and a favorable toxicokinetic profile. However, the insoluble nature of Z-GP-Dox becomes a significant barrier to drug administration, particularly when it comes to the clin...
Autores principales: | Zhang, Yuchen, Zhang, Xingwang, Liu, Hongming, Cai, Shaohui, Wu, Baojian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346364/ https://www.ncbi.nlm.nih.gov/pubmed/25759584 http://dx.doi.org/10.2147/IJN.S75954 |
Ejemplares similares
-
The FAPα-activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway
por: Ye, Geni, et al.
Publicado: (2022) -
One-pot synthesis and enzyme-responsiveness of amphiphilic doxorubicin prodrug nanomicelles for cancer therapeutics
por: Han, Ling-Na, et al.
Publicado: (2022) -
TPGS2000-DOX Prodrug Micelles for Improving Breast Cancer Therapy
por: Tang, Lan, et al.
Publicado: (2021) -
A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer
por: Houba, P H J, et al.
Publicado: (2001) -
Self-assembly of diclofenac prodrug into nanomicelles for enhancing the anti-inflammatory activity
por: Assali, Mohyeddin, et al.
Publicado: (2021)